These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21882508)

  • 1. [Placing of oral implants in patients using bisphosphonates].
    Verbruggen KH; de Visscher JG
    Ned Tijdschr Tandheelkd; 2011; 118(7-8):382-6. PubMed ID: 21882508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bisphosphonates and dental implants.
    McLeod NM
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1355. PubMed ID: 19446233
    [No Abstract]   [Full Text] [Related]  

  • 4. Dental endosseous implants in patients on bisphosphonate therapy.
    Scully C; Madrid C; Bagan J
    Implant Dent; 2006 Sep; 15(3):212-8. PubMed ID: 16966893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw.
    Wilde F; Heufelder M; Winter K; Hendricks J; Frerich B; Schramm A; Hemprich A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Feb; 111(2):153-63. PubMed ID: 20674411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implants and oral bisphosphonates: risky business?
    Otomo-Corgel J
    J Periodontol; 2007 Mar; 78(3):373-6. PubMed ID: 17335360
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Care required when using bisphosphonates in dental surgical practice.
    Goiato MC; dos Santos DM; Rondon BC; Moreno A; Baptista GT; Verri FR; Dekon SF
    J Craniofac Surg; 2010 Nov; 21(6):1966-70. PubMed ID: 21119471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.
    Goss A; Bartold M; Sambrook P; Hawker P
    J Oral Maxillofac Surg; 2010 Feb; 68(2):337-43. PubMed ID: 20116705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A; Payne AG; Zafar S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
    Van Poznak C; Estilo C
    Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
    SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates and avascular necrosis of alveolar bone: a potential threat to dental implants.
    Garg AK
    Dent Implantol Update; 2006 Oct; 17(10):73-8. PubMed ID: 17066981
    [No Abstract]   [Full Text] [Related]  

  • 14. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.
    Woo SB; Hellstein JW; Kalmar JR
    Ann Intern Med; 2006 May; 144(10):753-61. PubMed ID: 16702591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bisphosphonate-associated osteonecrosis of the jaws 1].
    Allard RH; Lips P; Eekhoff EM; van Merkesteyn JP; van der Waal I
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):423-7. PubMed ID: 17972610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review.
    Madrid C; Sanz M
    Clin Oral Implants Res; 2009 Sep; 20 Suppl 4():87-95. PubMed ID: 19663954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do Fosamax-type drugs increase the risk of osteonecrosis of the jaw for patients receiving dental implants?
    Wynn RL
    Gen Dent; 2008; 56(5):410-1. PubMed ID: 18683394
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE; Umland EM
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
    Radfar L; Masood F
    J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.